title: Women's experiences after Planned Parenthood's exclusion from a family planning program in Texas.
abstract: OBJECTIVE
  We assessed the impact on depot medroxyprogesterone continuation when a large care provider was banned from a state-funded family planning program.
  
  
  METHODS
  We used three methods to assess the effect of the ban: (a) In a records review, we compared how many state program participants returned to two Planned Parenthood affiliates for a scheduled dose of depot medroxyprogesterone acetate (DMPA) immediately after the ban; (b) We conducted phone interviews with 224 former Planned Parenthood patients about DMPA use and access to contraception immediately after the ban; (c) We compared current contraceptive method of our interviewees to that of comparable DMPA users in the National Survey of Family Growth 2006-2010 (NSFG).
  
  
  RESULTS
  (a) Fewer program clients returned for DMPA at a large urban Planned Parenthood, compared to a remotely located affiliate (14.4%, vs. 64.8%), reflecting different levels of access to alternative providers in the two cities. (b) Among program participants who went elsewhere for the injection, only 56.8% obtained it at no cost and on time. More than one in five women missed a dose because of barriers, most commonly due to difficulty finding a provider. (c) Compared to NSFG participants, our interviewees used less effective methods of contraception, even more than a year after the ban went into effect.
  
  
  CONCLUSIONS
  Injectable contraception use was disrupted during the rollout of the state-funded family planning program. Women living in a remote area of Texas encountered more barriers.
  
  
  CONCLUSIONS
  Requiring low-income family planning patients to switch healthcare providers has adverse consequences.
authors.affiliation: University of Texas School of Public Health, San Antonio Regional Campus, TX, USA. Electronic address: junda.woo@sanantonio.gov.
authors.forename: C Junda
authors.initials: CJ
authors.lastname: Woo
authors.affiliation: University of Texas School of Public Health, San Antonio Regional Campus, TX, USA.
authors.forename: Hasanat
authors.initials: H
authors.lastname: Alamgir
authors.affiliation: Population Research Center, University of Texas at Austin, TX, USA.
authors.forename: Joseph E
authors.initials: JE
authors.lastname: Potter
mesh_terms: D003267:Contraception; D003271:Contraceptive Agents, Female; D005193:Family Planning Services / Q000331:legislation & jurisprudence*; D005260:Female; D006297:Health Services Accessibility; D006801:Humans; D066149:International Planned Parenthood Federation / Q000331:legislation & jurisprudence*; D017258:Medroxyprogesterone Acetate / Q000008:administration & dosage; D011795:Surveys and Questionnaires; D013781:Texas; D014505:Urban Population; D016387:Women's Health
chemical_list: D003271:Contraceptive Agents, Female; D017258:Medroxyprogesterone Acetate
keywords: Contraceptive agents; Depo-Provera; Family planning policy; Family planning programs; Planned Parenthood Federation of America; Texas